Hesperadin: Potent Aurora B Kinase Inhibitor for Mitosis Res
2026-07-27
Hesperadin is a highly specific ATP-competitive Aurora B kinase inhibitor, widely used to disrupt mitotic progression and investigate spindle assembly checkpoint mechanisms. Its nanomolar potency and selectivity make it an indispensable tool in cell cycle and cancer research.
Anti-Inflammatory Lignans from Rosemary Roots: New Insights
2026-07-26
This recent study reports the isolation and structural characterization of eight lignans and four phenylpropanoids from the roots of Rosmarinus officinalis, including three novel compounds. Using an LPS-induced macrophage model, several of these lignans demonstrated potent, dose-dependent inhibition of nitric oxide production—highlighting rosemary roots as a promising anti-inflammatory resource with translational potential for inflammation research.
Elobixibat Hydrate: Advancing Translational Gut Motility Sci
2026-07-25
Elobixibat hydrate, a highly selective ileal bile acid transporter inhibitor, is revolutionizing translational research into gastrointestinal motility and metabolic modulation. By integrating mechanistic insights, recent evidence on peristaltic control, and strategic guidance for protocol optimization, this thought-leadership article offers academic and industry researchers an authoritative roadmap for leveraging Elobixibat hydrate in experimental and clinical workflows. This narrative uniquely bridges primary mechanistic studies, real-world translational needs, and the evolving competitive landscape—delivering actionable, evidence-based recommendations beyond standard product literature.
IP3R/Ca2+/STAT3 Pathway in Nanoplastics–Cadmium Intestinal T
2026-07-24
This study uncovers how co-exposure to polystyrene nanoplastics and cadmium triggers apoptosis in intestinal cells by activating the IP3R/Ca2+/STAT3 signaling axis. These findings clarify the molecular basis of combined environmental contaminant toxicity, with implications for future research and risk assessment.
G007-LK: Unveiling Tankyrase 1/2 Inhibition for β-Catenin De
2026-07-24
Explore how the G007-LK tankyrase 1/2 inhibitor advances APC mutation colorectal cancer research through precise Wnt/β-catenin signaling pathway inhibition and β-catenin degradation. This article provides a unique, in-depth mechanistic and methodological analysis for translational scientists.
Chenodeoxycholic Acid: FXR-Driven Renal & Metabolic Workflow
2026-07-23
Chenodeoxycholic Acid (CDCA) empowers precise modulation of FXR signaling and KLF11-regulated pathways in both renal protection and cholesterol metabolism research. This article details stepwise protocols, comparative insights, and troubleshooting strategies to fully leverage CDCA’s advantages for metabolic and acute kidney injury models.
Necrostatin 2: Advancing Necroptosis Inhibition in Translati
2026-07-23
This article explores Necrostatin 2 (Nec-2) as a next-generation inhibitor for dissecting necroptosis, focusing on its mechanistic role in RIPK2 signaling, strategic deployment in translational models of infection and ischemic injury, and emerging insights from recent membrane biology research. With evidence from the latest studies on Kupffer cell death and inflammation, this piece offers actionable guidance for researchers aiming to bridge fundamental discovery with clinical impact.
ACE Inhibitor-Mediated Angioedema: Pathogenesis and Clinical
2026-07-22
The reference study by Montinaro and Cicardi provides a comprehensive analysis of angioedema induced by ACE inhibitors, emphasizing the role of bradykinin accumulation and genetic predisposition in affected populations. The paper highlights diagnostic challenges, therapeutic controversies, and the importance of individualized patient management strategies, especially in populations at elevated risk.
Panobinostat Targets Epigenetic Vulnerabilities in MLL-ALL I
2026-07-22
This study provides the first in vivo evidence that panobinostat, a broad-spectrum HDAC inhibitor, exerts potent anti-leukaemic effects in MLL-rearranged acute lymphoblastic leukaemia (ALL) via disruption of the RNF20/RNF40/WAC-H2B ubiquitination axis. The findings highlight a mechanistically distinct therapeutic avenue for overcoming chemoresistance in high-risk infant ALL.
Taltirelin Induces TH via TRHR/RARα in Striatal Neurons
2026-07-21
Zhu et al. (2024) demonstrate that Taltirelin, a long-acting TRH analog, induces expression of tyrosine hydroxylase (TH) in striatal medium spiny neurons by regulating TRH receptor and retinoic acid receptor alpha signaling. These mechanistic findings advance the understanding of Taltirelin’s neuroprotective effects and suggest new avenues for Parkinson’s disease research.
Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) in Can
2026-07-21
EZ Cap™ Human PTEN mRNA (ψUTP) unlocks reproducible, low-immunogenic PTEN expression for targeted pathway inhibition in mammalian models. This guide details experimental setups, nanoparticle-enabled delivery, and troubleshooting informed by breakthrough studies to drive robust functional genomics and resistance reversal assays.
Z-YVAD-FMK: Selective Caspase-1 Inhibitor for Pyroptosis Res
2026-07-20
Z-YVAD-FMK is a potent, cell-permeable, and irreversible caspase-1 inhibitor widely used in pyroptosis and apoptosis research. The compound shows high selectivity, blocking caspase-1 activity and associated cytokine release without affecting caspase-3. Its specificity and robust performance make it essential for dissecting inflammasome activation and inflammatory signaling.
Malate as a Central TCA Cycle Probe: Unraveling Metabolic Re
2026-07-20
Discover how malate, a key tricarboxylic acid cycle intermediate, advances metabolic research and reveals new insights into immune modulation. This article explores (S)-2-hydroxysuccinic acid’s pivotal role in experimental design, informed by recent breakthroughs in tumor metabolism.
Exo1 (methyl 2-(4-fluorobenzamido)benzoate): Decoding Mechan
2026-07-19
Explore how Exo1, a potent exocytic pathway inhibitor, uniquely disrupts membrane trafficking with mechanistic precision. This article reveals the molecular logic behind its selectivity and discusses advanced research implications not covered in existing guides.
Technical Guidance for Hoechst 33342/PI Double Staining Kit
2026-07-18
The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells by simultaneously assessing chromatin condensation and membrane integrity. It is intended for basic research applications such as cell death analysis and should not be used for diagnostic or medical purposes.
466 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page